600535.SS SHH
Tasly Pharmaceutical Group Co., Ltd
1W: +0.4%
1M: -4.6%
3M: +1.7%
YTD: -6.4%
1Y: -12.0%
3Y: +10.8%
5Y: +19.4%
¥14.00 ($2.09)
+0.26 (+1.89%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTM¥8B
Revenue
-3.2% YoY
¥1B
Net Income
+14.6% YoY
¥2B
Free Cash Flow
+26.1% YoY
70.7%
Gross Margin
28.8%
Op. Margin
25.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE9.6%
ROA7.9%
ROIC11.9%
Valuation
P/E1.6
P/B0.1
EV/EBITDA-1.4
Leverage
Debt/Equity0.05
Current Ratio4.85
Interest Cov.82.2x
Quality Scores
Piotroski F8/9
Altman Z2.48
Beneish M-2.03